Detalhe da pesquisa
1.
Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment.
Proc Natl Acad Sci U S A
; 120(32): e2305046120, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523559
2.
Risk-reducing decisions regarding germline BRCA pathogenic variant: focusing on the timing of genetic testing and RRSO.
J Med Genet
; 61(4): 392-398, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124001
3.
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.
Br J Cancer
; 130(6): 1023-1035, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238427
4.
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
J Natl Compr Canc Netw
; 22(2D)2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744306
5.
Socioeconomic status and incident depressive symptoms among older adults: A 3-year longitudinal study from the Japan Gerontological Evaluation Study.
Int J Geriatr Psychiatry
; 39(2): e6069, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357974
6.
Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
Breast Cancer Res
; 25(1): 21, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810117
7.
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.
Cancer Sci
; 114(12): 4632-4642, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858313
8.
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.
Br J Cancer
; 128(7): 1208-1222, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725920
9.
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Breast Cancer Res Treat
; 202(3): 485-496, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676450
10.
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Breast Cancer Res Treat
; 202(3): 473-483, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688665
11.
Childbirth after perioperative systemic therapy in patients with breast cancer: a retrospective single institutional study in Japan.
Jpn J Clin Oncol
; 53(6): 457-462, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974683
12.
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.
Cancer Sci
; 113(7): 2336-2351, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35415910
13.
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Cancer Sci
; 113(9): 3169-3179, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35754298
14.
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.
Cancer Sci
; 113(5): 1808-1820, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201661
15.
Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer.
Breast Cancer Res Treat
; 196(2): 341-348, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153381
16.
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
BMC Med
; 20(1): 136, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462552
17.
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.
BMC Med
; 20(1): 105, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296300
18.
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.
BMC Cancer
; 22(1): 36, 2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983437
19.
Functional disability trajectories at the end of life among Japanese older adults: findings from the Japan Gerontological Evaluation Study (JAGES).
Age Ageing
; 51(11)2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413588
20.
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(1): 74-84, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387497